Sub menu

 

 

Review of the management of adverse events associated with Panvax and Fluvax

Published

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application.

Professor John Horvath has reviewed the use of influenza vaccines in Australia and our system for reporting adverse events following vaccination.

Related content

  • Cannabis-like drugs to be outlawed

    Media releases
    Eight synthetic cannabis-like substances will be classified as prohibited substances throughout Australia from 8 July, Parliamentary Secretary for Health and Ageing, Catherine King, has announced.

  • TGA Transparency review released

    Media releases
    The Australian Government today released the report of the Therapeutic Goods Administration (TGA) Transparency Review panel, chaired by Professor Dennis Pearce.